Xiaoying Hu

3.2k citations
42 papers · 2.1k indexed · 3 hit papers · h-index 17

Xiaoying Hu

39 papers receiving 2.1k citations

Hit Papers

Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer A...4062018202620202023200400600

Peers

Xiaoying Hu
Comparison fields: 5 of 110
  • Immunology 1.3k
  • Oncology 981
  • Nephrology 107
  • Cancer Research 189
  • Pulmonary and Respiratory Medicine 232
Replace Fred Fändrich with:
Fred Fändrich Germany
Achille Anselmo Italy
Jason L. Gaglia United States
Thian Kui Tan Australia
Giovanni Ligresti United States
Katri S. Selander Finland
Yoshifumi Takei Japan
Francesco Del Galdo United Kingdom
Monika Lodyga Canada
Huiming Sheng China
Xiaoying Hu relative to Fred Fändrich Germany Fred Fändrich's profile →
Citations per field
00.5×4.9×
Fred Fändrich · 1×
Citations per year

Countries citing papers authored by Xiaoying Hu

Since Specialization
Citations

This map shows the geographic impact of Xiaoying Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoying Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoying Hu more than expected).

Fields of papers citing papers by Xiaoying Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoying Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoying Hu. The network helps show where Xiaoying Hu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xiaoying Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoying Hu Line = papers co-authored together Xiaoying Hu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20243
4 20241
5 20241
6 20243
7 202232
8 20223
9 202234
10 2019110
11 201922
12 201940
13
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppressionbreakdown →
2018355
14 201842
15
Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progressionbreakdown →
2018614
16 20172
17 201725
18 201664
19 20125
20 200733

About Xiaoying Hu

Xiaoying Hu is a scholar working on Nephrology, Immunology and Family Practice, having authored 42 papers that have together received 2.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (7 papers), Immune cells in cancer (7 papers), Coronary Interventions and Diagnostics (5 papers), Acute Kidney Injury Research (5 papers), Chronic Kidney Disease and Diabetes (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cardiac Imaging and Diagnostics (3 papers) and Renal Diseases and Glomerulopathies (3 papers). The work is most often cited by research in Immunology (1.3k citations), Oncology (981 citations) and Nephrology (107 citations). Xiaoying Hu has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Jochen Utikal, Peter Altevogt, Rebekka Weber, Christopher Groth, Viktor Fleming, Viktor Umansky, Vasyl S. Nagibin, Viktor Umansky, Hong Qiu and Laura Hüser. Their work appears in journals such as Journal of the American College of Cardiology, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026